Sesen Bio
Is working on developing a new treatment for bladder cancer.
Launch date
Employees
Market cap
AUD184m
Enterprise valuation
(AUD74m) (Public information from Mar 2023)
Share price
$0.6288 SESN
Cambridge Massachusetts (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$35.0m | Series A | ||
$20.0m | Early VC | ||
N/A | N/A | IPO | |
N/A | $20.0m | Post IPO Equity | |
* | $40.0m | Post IPO Equity | |
N/A | $8.0m | Post IPO Equity | |
* | N/A | Acquisition | |
Total Funding | AUD85.0m |
Related Content
Recent News about Sesen Bio
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.